EDP Sciences logo
Subscriber Authentication Point
Search
Menu
Home All issues Volume 25 / No 10 (Octobre 2009) Med Sci (Paris), 25 10 (2009) 847-854 References
Issue
Med Sci (Paris)
Volume 25, Number 10, Octobre 2009
Accidents vasculaires cérébraux
Page(s) 847 - 854
Section M/S revues : Accidents vasculaires cérébraux (2)
DOI https://doi.org/10.1051/medsci/20092510847
Published online 15 October 2009
  1. Donnan GA, Fisher M, Macleod M, Davis SM. Stroke. Lancet 2008; 371 : 1612–32. [Google Scholar]
  2. Hacke W, Kaste M, Bluhmki E, et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 2008; 359 : 1317–29. [Google Scholar]
  3. Ginsberg MD. Neuroprotection for ischemic stroke: past, present and future. Neuropharmacology 2008; 55 : 363–89. [Google Scholar]
  4. Del Zoppo GJ. Inflammation and neurovascular unit in the setting of focal cerebral ischemia. Neuroscience 2009; 158 : 972–82. [Google Scholar]
  5. Shpargel KB, Jalabi W, Jin Y, et al. Preconditioning paradigms and pathways in the brain. Cleve Clin J Med 2008; 75 : S77–82. [Google Scholar]
  6. Hess DC, Borlongan CV. Cell-based therapy in ischemic stroke. Expert Rev Neurother 2008; 8 : 1193–201. [Google Scholar]
  7. Endres M, Engelhardt B, Koistinaho J, et al. Improving outcome after stroke : overcoming the translational roadblock. Cerebrovasc Dis 2008; 25 : 268–78. [Google Scholar]
  8. Obrenovitch TP. Molecular physiology of preconditioning-induced brain tolerance to ischemia. Physiol Rev 2008; 88 : 211–47. [Google Scholar]
  9. Stenzel-Poore MP, Stevens SL, King JS, Simon RP. Preconditioning reprograms to response to ischemic injury and primes the emergence of unique endogenous neuroprotective phenotypes : a speculative synthesis. Stroke 2007; 38 (suppl 2) : 680–5. [Google Scholar]
  10. Bastide M, Ouk T, Plaisier F, et al. Neurogliovascular unit after cerebral ischemia: is the vascular wall a pharmacological target. Psychoneuroendocrinology 2007; 32 : S36–9. [Google Scholar]
  11. Goldstein LB. Statins and ischemic stroke severity: cytoprotection. Curr Atheroscler Rep 2009; 11 : 296–300. [Google Scholar]
  12. Bordet R, Ouk T, Petrault O, et al. PPAR: a new pharmacological target for neuroprotection in stroke and neurodegenerative diseases. Biochem Soc Trans 2006; 34 : 1341–6. [Google Scholar]
  13. Blondeau N, Widmann C, Lazdunski M, Heurtaux C. Polyunsaturated fatty acids induce ischemic and epileptic tolerance. Neuroscience 2002; 109 : 231–41. [Google Scholar]
  14. Deplanque D, Masse I, Lefebvre C, et al. Prior TIA, lipid-lowering drug use, and physical activity decrease ischemic stroke severity. Neurology 2006; 67 : 1403–10. [Google Scholar]
  15. Zaleska MM, Mercado ML, Chavez J, et al. The development of stroke therapeutics: promising mechanisms and translational challenges. Neuropharmacology 2009; 56 : 329–41. [Google Scholar]
  16. Bordet R, Lestage P, Onteniente B. The concept of neuroprotective agents as a treatment modulators in the development of brain diseases. Therapie 2007; 62 : 463–72. [Google Scholar]
  17. Fisher M, Feuerstein G, Howells DW, et al. Update of the stroke therapy academic industry roundtable preclinical recommendations. Stroke 2009; 40 : 2244–50. [Google Scholar]
  18. Feuerstein GZ, Zaleska MM, Krams M, et al. Missing steps in the STAIR case : a translational medicine perspective on the development of NXY-059 for treatment of acute ischemic stroke. J Cereb Blood Flow Metab 2008; 28 : 217–9. [Google Scholar]
  19. Benchenane K, Castel H, Boulouard M, et al. Anti-NR1 N-terminal-domain vaccination unmasks the crucial action of tPA on NMDA-receptor-mediated toxicity and spatial memory. J Cell Sci 2007; 120 : 578–85. [Google Scholar]
  20. Heurtaux C, Laigle C, Blondeau N, et al. Alpha-linolenic acid and riluzole treatment confer cerebral protection and improve survival after focal brain ischemia. Neuroscience 2006; 137 : 241–51. [Google Scholar]
  21. Haddad M, Rhinn H, Bloquel C, et al. Anti-inflammatory effects of PJ34, a poly (ADP-ribose) polymerase inhibitor, in transcient focal cerebral ischemial in mice. Br J Pharmacol 2006; 149 : 23–30. [Google Scholar]
  22. Chauvier D, Ankri S, Charriaut-Marlangue C, et al. Broad-spectrum caspase inhibitors : from myth to reality ? Cell Death Differ 2007; 14 : 387–91. [Google Scholar]
  23. Onténiente B. Natural and synthetic inhibitors of caspases : targets for novel drugs. Curr Drug Targets CNS Neurol Disord 2004; 3 : 333–40. [Google Scholar]
  24. Guégan C, Braudeau J, Couriaud C, et al. PTD-XIAP protects against cerebral ischemia by anti-apoptotic and transcriptional regulatory mechanisms. Neurobiol Dis 2006; 22 : 177–86. [Google Scholar]
  25. Spahn A, Blondeau N, Heurteaux C, et al. Concomitant transitory up-regulation of X-linked inhibitor of apoptosis protein (XIAP) and the heterogeneous nuclear ribonucleoprotein C1-C2 in surviving cells during neuronal apoptosis. Neurochem Res 2008; 33 : 1859–68. [Google Scholar]
  26. Lok J, Gupta P, Guo S, et al. Cell-cell signalling in neurovascular unit. Neurochem Res 2007; 32 : 2032–45 [Google Scholar]
  27. Villapol S, Gelot A, Renolleau S, Charriaut-Marlangue C. Astrocyte responses after neonatal ischemia : the yin and the yang. Neuroscientist 2008; 14 : 339–44. [Google Scholar]
  28. Amantea D, Nappi G, Bernardi G, et al. Post-ischemic brain damage : pathophysiology and role of inflammatory mediators. FEBS J 2009; 276 : 13–26. [Google Scholar]
  29. Fisher M. Injuries to the vascular endothelium: vascular wall and endothelial dysfunction. Rev Neurol Dis 2008; 5 : S4–11. [Google Scholar]
  30. Gautier S, Ouk T, Petrault O, et al. Neutrophils contribute to intracerebral haemorrhages after treatment with recombinant tissue plasminogen activator following cerebral ischaemia. Br J Pharmacol 2009; 156 : 673–9. [Google Scholar]
  31. Zhao BQ, Tejima E, Lo EH. Neurovascular proteases in brain injury, hemorrhage and remodeling after stroke. Stroke 2007; 38 (suppl 2) : 748–52. [Google Scholar]
  32. Minnerup J, Schäbitz WR. Multifunctional actions of approved and candidate stroke drugs. Neurotherapeutics 2009; 6 : 43–52. [Google Scholar]
  33. Rodriguez-Gonzalez R, Hurtado O, Sobrino T, Castillo J. Neuroplasticity and cellular therapy in cerebral infarction. Cerebrovasc Dis 2007; 24 : S167–80. [Google Scholar]
  34. Tardy J, Pariente J, Leger A, et al. Methylphenidate modulates cerebral post-stroke reorganization. Neuroimage 2006; 33 : 913–22. [Google Scholar]
  35. Bacigaluppi M, Pluchino S, Martino G, et al. Neural stem/precursor cells for the treatment of ischemic stroke. J Neurol Sci 2008; 265 : 73–7. [Google Scholar]
  36. Vivien D, Gauberti M, Guedin P, Anglés-Cano E. Comment optimiser l’utilisation du tPA ? Med Sci (Paris) 2009; 25 : 855–7. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.